HCP Cureblindness brings focus to avoidable vision loss for World Sight Day

News
Article

Every October, World Sight Day brings awareness to the global challenges of blindness and vision impairment

An AI-generated eye with a globe in the iris. Image credit: ©Real Fantasy Art – stock.adobe.com

"This World Sight Day, HCP is shining a light on why avoidable blindness can – and must – be overcome," said K-T Overbey, HCP's CEO. Image credit: ©Real Fantasy Art – stock.adobe.com

The Himalayan Cataract Project (HCP Cureblindness) recognizes World Sight Day by bringing attention to avoidable blindness worldwide. The project's mission is to to help individuals in developing countries retain and regain their sight.

World Sight Day is an annual day of awareness held the second Thursday in October. This year, HCP announced in a press release it will also be supporting the International Agency for the Prevention of Blindness (IAPB) #LoveYourEyes at Work campaign, which encourages workplace vision screenings globally.

Forty-three million people globally are blind, while another 295 million suffer from moderate-to-severe vision impairment, stated HCP in the release.1 Furthermore, 90% of these individuals live in low-to-middle income countries.

According to the release from HCP, vision loss causes over $400 billion in lost productivity annually and reduces employment. In people with blindness or moderate-to-severe vision impairment, overall reduction in employment is 30%. While the risk of premature mortality is 157% higher for people with blindness and 49% higher for people with vision loss that is moderate to severe or worse.

"This World Sight Day, HCP is shining a light on why avoidable blindness can – and must – be overcome," said K-T Overbey, HCP's CEO. "For more than 25 years, HCP has worked alongside a capable network of collaborators to help people globally retain and regain their sight by developing high-quality, cost-effective eye care systems in underserved areas of the world."

HCP states the solution lies in cataracts and corneal blindness awareness. “With early detection and treatment, the impact of many causes of blindness can be treated – and often cured – improving the quality of life for those individuals affected,” said the organization in the release.

According to the release1 almost half of all blindness is due to cataracts, and there are millions who suffer from corneal blindness which, in most cases, is preventable or treatable.

Reference:

  1. World Sight Day is October 12, 2023 - HCP Cureblindness Shines Light on Avoidable Blindness and Its Mission to Help Individuals in Underserved Countries Retain and Regain Their Sight. Press Release. Released October 5, 2023. Accessed October 9, 2023. https://www.prnewswire.com/news-releases/world-sight-day-is-october-12-2023---hcp-cureblindness-shines-light-on-avoidable-blindness-and-its-mission-to-help-individuals-in-underserved-countries-retain-and-regain-their-sight-301947960.html
Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.